Numerous studies demonstrate the effectiveness of TMS for patients with treatment-resistant depression, yielding response rates of 50-60% and sustained improvements with continued sessions, making it a transformative option in mental health care and the cure for depression.
Ongoing clinical trials are investigating optimizations in TMS, including variations in pulse intensity and frequency, as well as its applicability in comorbid psychiatric disorders and neurodegenerative diseases, representing an exciting frontier in neurotherapy.